Valeur Intrinsèque du S&P et Nasdaq Contactez-nous

Atreca, Inc. BCEL NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
38/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$4.00
+4344.4%

Il y a eu 50 transactions d'initiés récentes enregistrées pour Atreca, Inc. (BCEL), dont 27 achats et 21 ventes. Le total des achats d'initiés s'élève à $2.5M et le total des ventes d'initiés à $3.44M.

Les initiés notables ayant une activité récente comprennent Orwin John A, Serafini Tito, Baker Bros. Advisors Lp. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — BCEL

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2024-04-11 Orwin John A President & CEO Achat Informatif 1 $0.01 $0.01 1
2024-04-01 Serafini Tito Director Vente Informative 20,788 $0.07 $1.46K 43,636
2023-10-19 Baker Bros. Advisors Lp Officer Vente Informative 22,837 $0.40 $9.19K 286,893
2023-09-17 Ruiz Roger Richard VP of Finance Cession 50,000 $1.49 $74.5K -
2023-09-01 Serafini Tito Director Vente Informative 8,393 $0.37 $3.14K 64,424
2023-09-01 Orwin John A President & CEO Vente Informative 22,951 $0.37 $8.6K 77,541
2023-09-01 Courtney Phillips General Counsel & Secretary Vente Informative 7,061 $0.37 $2.65K 50,431
2023-08-02 Cross Herb Chief Financial Officer Vente Informative 5,487 $0.95 $5.22K 72,817
2023-08-02 Serafini Tito Chief Strategy Officer Vente Informative 5,487 $0.95 $5.22K 72,817
2023-08-02 Courtney Phillips General Counsel & Secretary Vente Informative 4,076 $0.95 $3.88K 57,492
2023-08-02 Gould Stephen E Chief Scientific Officer Vente Informative 4,076 $0.95 $3.88K 28,424
2023-06-13 Ball Kristine M Director Attribution de RSU 12,000 $1.18 $14.16K 12,000
2023-06-13 Atwood Brian G Director Attribution de RSU 12,000 $1.18 $14.16K 12,000
2023-06-13 Berger Franklin M Director Attribution de RSU 12,000 $1.18 $14.16K 12,000
2023-06-13 Brady Stephen R Director Attribution de RSU 12,000 $1.18 $14.16K 12,000
2023-06-13 Rolfe Lindsey Director Attribution de RSU 12,000 $1.18 $14.16K 12,000
2023-06-13 Lacey David L. Director Attribution de RSU 12,000 $1.18 $14.16K 12,000
2023-06-13 Robinson William Hewitt Director Attribution de RSU 12,000 $1.18 $14.16K 12,000
2023-06-13 Ma Stacey Director Attribution de RSU 12,000 $1.18 $14.16K 12,000
2023-02-09 Cross Herb Chief Financial Officer Attribution de RSU 43,750 - - 78,304
2023-02-09 Serafini Tito Chief Strategy Officer Retour de RSU 43,750 - - 78,304
2023-02-09 Orwin John A President & CEO Attribution de RSU 435,000 $1.49 $648.15K 435,000
2023-02-09 Courtney Phillips General Counsel & Secretary Attribution de RSU 32,500 - - 61,568
2023-02-09 Gould Stephen E Chief Scientific Officer Attribution de RSU 32,500 - - 32,500
2023-01-09 Bishop Philippe C Officer Inconnu - - - -
2023-01-09 Bishop Philippe C Chief Medical Officer Attribution de RSU 350,000 - - 350,000
2022-09-02 Serafini Tito Chief Strategy Officer Vente Informative 7,646 $1.78 $13.57K 34,554
2022-09-02 Orwin John A President & CEO Vente Informative 20,908 $1.78 $37.12K 100,492
2022-09-02 Courtney Phillips General Counsel & Secretary Vente Informative 6,432 $1.78 $11.42K 29,068
2022-06-28 Serafini Tito Chief Strategy Officer Vente Informative 15,000 $2.02 $30.27K 228,875
2022-06-15 Gould Stephen E Officer Inconnu - - - -
2022-06-15 Gould Stephen E Chief Scientific Officer Attribution de RSU 200,000 - - 200,000
2022-06-13 Cross Herb Chief Financial Officer Restitution d'Actions 97,000 - - -
2022-06-13 Serafini Tito Chief Strategy Officer Restitution d'Actions 95,000 $13.97 $1.33M -
2022-06-13 Orwin John A President & CEO Restitution d'Actions 58,995 - - -
2022-06-13 Courtney Phillips General Counsel & Secretary Restitution d'Actions 91,666 $17.00 $1.56M -
2022-06-08 Ball Kristine M Director Attribution de RSU 12,000 - - 12,000
2022-06-08 Berger Franklin M Director Attribution de RSU 12,000 $2.09 $25.08K 12,000
2022-06-08 Brady Stephen R Director Attribution de RSU 12,000 - - 12,000
2022-06-08 Rolfe Lindsey Director Attribution de RSU 12,000 $2.09 $25.08K 12,000
2022-06-08 Lacey David L. Director Attribution de RSU 12,000 - - 12,000
2022-06-08 Robinson William Hewitt Director Attribution de RSU 12,000 - - 12,000
2022-06-08 Ma Stacey Director Attribution de RSU 12,000 - - 12,000
2022-06-08 Atwood Brian G Director Attribution de RSU 12,000 - - 12,000
2022-03-04 Serafini Tito Chief Strategy Officer Vente Informative 30,000 $5.00 $150K 243,875
2021-12-23 Cross Herb Chief Financial Officer Attribution de RSU 95,000 $3.18 $302.1K 95,000
2021-12-23 Serafini Tito Chief Strategy Officer Attribution de RSU 95,000 $3.18 $302.1K 95,000
2021-12-23 Orwin John A President & CEO Attribution de RSU 260,000 $3.18 $826.8K 260,000
2021-12-23 Courtney Phillips General Counsel & Secretary Attribution de RSU 80,000 $3.18 $254.4K 80,000
2021-09-27 Serafini Tito Chief Strategy Officer Vente Informative 30,000 $6.58 $197.54K 273,875
Informatif — transaction sur marché ouvert (la plus significative) Non informatif (achat) — récompense, exercice d'option, conversion Non informatif (vente) — retenue fiscale, vente à l'acquisition Neutre — don, fiducie, expiration
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
Envoyez-nous un message